SEARCH

SEARCH BY CITATION

References

  • 1
    Skelly BJ, Franklin JM. Recognition and diagnosis of lysosomal storage diseases in the cat and dog. J Vet Intern Med 2002;16:133141.
  • 2
    Warren CD, Alroy J. Morphological, biochemical and molecular biology approaches for the diagnosis of lysosomal storage diseases. J Vet Diagn Invest 2000;12:483496.
  • 3
    Gravel RA, Kaback MM, Proia RL, et al. GM2 gangliosidosis. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw-Hill; 2001:38273876.
  • 4
    Bernheimer H, Karbe E. Morphologische und neurochemische Untersuchungen von 2 Formen der amaurotischen Idiotie des Hundes: Nachweis einer G-Gangliosidose. Acta Neuropathol 1970;16:243261.
  • 5
    Gambetti LA, Kelly AM, Steinberg SA. Biochemical studies in a canine gangliosidosis. J Neuropathol Exp Neurol 1970;29:137138.
  • 6
    Cummings JF, Wood PA, Walkley SU, et al. GM2 gangliosidosis in a Japanese Spaniel. Acta Neuropathol 1985;67:247253.
  • 7
    Rotmistrovsky RA, Alcaraz A, Cummings JC, et al. GM2 gangliosidosis in a mixed-breed dog. Prog Vet Neurol 1991;2:203208.
  • 8
    Yamato O, Matsuki N, Satoh H, et al. Sandhoff disease in a Golden Retriever dog. J Inherit Metab Dis 2002;25:319320.
  • 9
    Cork LC, Munnell JF, Lorenz MD, et al. GM2 ganglioside lysosomal storage disease in cats with β-hexosaminidase deficiency. Science 1977;196:10141017.
  • 10
    Neuwelt EA, Johnson WG, Blank NK, et al. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J Clin Invest 1985;76:482490.
  • 11
    Yamato O, Matsunaga S, Takata K, et al. GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats. Vet Rec 2004;155:739744.
  • 12
    Martin DR, Cox NR, Morrison NE, et al. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathol 2005;110:443450.
  • 13
    Bradbury AM, Morrison NF, Hwang M, et al. Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase β-subunit deficiency. Mol Genet Metab 2009;97:5359.
  • 14
    Read WK, Bridges CH. Cerebrospinal lipodystrophy in swine. A new disease model in comparative pathology. Pathol Vet 1968;5:6774.
  • 15
    Pierce KR, Kosanke SD, Bay WW, Bridges CH. Animal model of human disease: GM2 gangliosidosis. Am J Pathol 1976;83:419422.
  • 16
    Fox J, Li YT, Dawson G, et al. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis). Acta Neuropathol 1999;97:5762.
  • 17
    Zeng BJ, Torres PA, Viner TC, et al. Spontaneous appearance of Tay-Sachs disease in an animal model. Mol Genet Metab 2008;95:5965.
  • 18
    Singer HS, Cork LC. Canine GM2 gangliosidosis: Morphological and biochemical analysis. Vet Pathol 1989;26:114120.
  • 19
    Eto Y, Ida H, Umezawa F, et al. Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. Tohoku J Exp Med 1987;152:333338.
  • 20
    Yamato O, Ochiai K, Masuoka E, et al. GM1 gangliosidosis in Shiba dogs. Vet Rec 2000;146:493496.
  • 21
    Yamato O, Satoh H, Matsuki N, et al. Laboratory diagnosis of canine GM2-gagnliosidosis using blood and cerebrospinal fluid. J Vet Diagn Invest 2004;16:3944.
  • 22
    Matsuki N, Yamato O, Kusuda M, et al. Magnetic resonance imaging of GM2-gangliosidosis in a Golden Retriever. Can Vet J 2005;46:275278.
  • 23
    Karbe E. Animal model: Canine GM2-gangliosidosis. Am J Pathol 1973;71:151154.
  • 24
    Yamato O, Masuoka Y, Yonemura M, et al. Clinical and clinico-pathologic characteristics of Shiba dogs with a deficiency of lysosomal acid β-galactosidase: A canine model of human GM1 gangliosidosis. J Vet Med Sci 2003;65:213217.
  • 25
    Yüksel A, Yalçinkaya C, Islak C, et al. Neuroimaging findings of four patients with Sandhoff disease. Pediatr Neurol 1999;21:562565.
  • 26
    Kroll RA, Pagel MA, Roman-Goldstein S, et al. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): Correlation of MR findings with pathologic and ultrastructural abnormalities. Am J Neuroradiol 1992;16:12191226.
  • 27
    Hesegawa D, Yamato O, Kobayashi M, et al. Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat. J Feline Med Surg 2007;9:232237.
  • 28
    Kaye EM, Alroy J, Raghavan SS, et al. Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr Neurol 1992;8:255261.
  • 29
    Van Der Voorn JP, Pouwels PJW, Kamphorst W, et al. Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. Am J Neuroradiol 2005;26:442446.
  • 30
    Nakamoto Y, Yamato O, Itamoto K, et al. Cranial MRI findings for three Shiba dogs diagnosed with GM1-gangliosidosis using a genetic test. J Jpn Vet Med Assoc 2009;62:219224 (in Japanese with English summary).
  • 31
    Martin DR, Krum BK, Baradarajan GS, et al. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant. Exp Neurol 2004;187:3037.
  • 32
    Muldoon LL, Neuwelt EA, Pagel MA, et al. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am J Pathol 1994;144:11091118.
  • 33
    Kanae Y, Endoh D, Yamato O, et al. Nonsense mutation of feline β-hexosaminidase β-subunit (HEXB) gene causing Sandhoff disease in a family of Japanese domestic cats. Res Vet Sci 2007;82:5460.